Utah Medical Products Inc
UTMD· Nasdaq
Released Jul 24, 2025, during market hours
10-Q filed Aug 12, 2025, 43 days after period end · 0001096906-25-001281
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $9.95M | $10.40M | $12.87M | $13.43M |
| Net Income | $3.05M | $3.45M | $4.20M | $4.10M |
| EPS Diluted |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $0.94 |
| $0.98 |
| $1.15 |
| $1.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.